Publication: 3935

Publication: 3935

Updated Progression-Free Survival from PRESTO: a Phase 3 Randomized Study of Androgen Annihilation for High-Risk Biochemically Relapsed Prostate Cancer (AFT-19)

DOI

URL

Google Scholar

Citation:: Journal of Urology vol 209 (suppl 4) e1191

Meeting Instance:: AUA 2023
Year:: 2023
Type:: Abstract
Sub type:
Funding:: AFT
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: epreprint

Note:

Methodological:: No
Biospecimen:: No
SDC:: Yes

Parents:: None
Children:: 4065

Program:: OGC
Primary Committee:: GU
Sec. Committees:

Pharmas:: Janssen
Grants:

Corr. Author:
Authors:: Rahul Aggarwal Scott E. Eggener Glenn Heller David Hillman Han Xiao Joel Picus Jennifer Wang Mary-Ellen Taplin Tanya Dorff Leonard Appleman Douglas Weckstein Akash Patnaik Alan Bryce Daniel Shevrin Susan Halabi James Mohler Daniel Anderson Arpit Rao Scott Tagawa Alan Tan Charles J. Ryan Michael J. Morris

Networks:: CA043, CA824, IL018, LAPS-IL057, LAPS-MA036, LAPS-MO011, LAPS-NY016, LAPS-NY158, LAPS-PA015, LAPS-TN008, LAPS-TX035, METROMIN, MN022, NH038, NY018, TX041

Study: AFT-19
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords: